LAZARO ALMEIDA: Open Payments
NPI 1881623353 · TRINITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$738 in 41 payments from 15 companies in 2025. Trend: 2023 $649 · 2024 $81 · 2025 $738
Food & beverage: $738
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $140 |
| ABBVIE INC. | 5 | $101 |
| AstraZeneca Pharmaceuticals LP | 6 | $94 |
| Esperion Therapeutics, Inc. | 5 | $90 |
| GlaxoSmithKline, LLC. | 3 | $60 |
| Amgen Inc. | 3 | $51 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $31 |
| SANOFI-AVENTIS U.S. LLC | 1 | $25 |
| Merck Sharp & Dohme LLC | 1 | $22 |
Products named: NEXLETOL, VRAYLAR, Wegovy, OTEZLA, BREZTRI, AIRSUPRA, TRELEGY ELLIPTA, Ozempic.
Industry payments across FL — which companies pay providers there.
